{"id":"https://openalex.org/W1964026490","doi":"https://doi.org/10.1002/hep.510240407","title":"Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by Rifampin","display_name":"Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by Rifampin","publication_year":1996,"publication_date":"1996-10-01","ids":{"openalex":"https://openalex.org/W1964026490","doi":"https://doi.org/10.1002/hep.510240407","mag":"1964026490","pmid":"https://pubmed.ncbi.nlm.nih.gov/8855178"},"language":"en","primary_location":{"id":"doi:10.1002/hep.510240407","doi":"https://doi.org/10.1002/hep.510240407","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.510240407","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.510240407","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.510240407","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030993480","display_name":"Martin F. Fromm","orcid":"https://orcid.org/0000-0002-0334-7478","observed_orcids":["https://orcid.org/0000-0002-0334-7478"]},"institutions":[{"id":"https://openalex.org/I4210120009","display_name":"Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology","ror":"https://ror.org/02pnjnj33","country_code":"DE","type":"facility","lineage":["https://openalex.org/I2802101015","https://openalex.org/I4210120009","https://openalex.org/I4403386655"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M F Fromm","raw_affiliation_strings":["Dr. Margarete Fischer-Bosch-Institut f\u00fcr Klinische Pharmakologie, Stuttgart, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Margarete Fischer-Bosch-Institut f\u00fcr Klinische Pharmakologie, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210120009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080654301","display_name":"Dagmar Busse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120009","display_name":"Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology","ror":"https://ror.org/02pnjnj33","country_code":"DE","type":"facility","lineage":["https://openalex.org/I2802101015","https://openalex.org/I4210120009","https://openalex.org/I4403386655"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D Busse","raw_affiliation_strings":["Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie, Stuttgart, Germany","Dr. Margarete Fischer\u2010Bosch\u2010Institut f\u00fcr Klinische Pharmakologie, Stuttgart, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210120009"]},{"raw_affiliation_string":"Dr. Margarete Fischer\u2010Bosch\u2010Institut f\u00fcr Klinische Pharmakologie, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210120009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108803606","display_name":"Heyo K. Kroemer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120009","display_name":"Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology","ror":"https://ror.org/02pnjnj33","country_code":"DE","type":"facility","lineage":["https://openalex.org/I2802101015","https://openalex.org/I4210120009","https://openalex.org/I4403386655"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H K Kroemer","raw_affiliation_strings":["Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie, Stuttgart, Germany","Dr. Margarete Fischer\u2010Bosch\u2010Institut f\u00fcr Klinische Pharmakologie, Stuttgart, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210120009"]},{"raw_affiliation_string":"Dr. Margarete Fischer\u2010Bosch\u2010Institut f\u00fcr Klinische Pharmakologie, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210120009"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023657124","display_name":"Michel F Eichelbaum","orcid":"https://orcid.org/0000-0001-5029-8472","observed_orcids":["https://orcid.org/0000-0001-5029-8472"]},"institutions":[{"id":"https://openalex.org/I4210120009","display_name":"Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology","ror":"https://ror.org/02pnjnj33","country_code":"DE","type":"facility","lineage":["https://openalex.org/I2802101015","https://openalex.org/I4210120009","https://openalex.org/I4403386655"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M Eichelbaum","raw_affiliation_strings":["Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie, Stuttgart, Germany","Dr. Margarete Fischer\u2010Bosch\u2010Institut f\u00fcr Klinische Pharmakologie, Stuttgart, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210120009"]},{"raw_affiliation_string":"Dr. Margarete Fischer\u2010Bosch\u2010Institut f\u00fcr Klinische Pharmakologie, Stuttgart, Germany","institution_ids":["https://openalex.org/I4210120009"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210120009"],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":null,"fwci":9.9721,"has_fulltext":true,"cited_by_count":279,"citation_normalized_percentile":{"value":0.99173967,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"24","issue":"4","first_page":"796","last_page":"801"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.8519999980926514},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cyp3a4-induction","display_name":"CYP3A4 induction","score":0.8370000123977661},{"id":"https://openalex.org/keywords/liver-metabolism","display_name":"hepatic metabolism","score":0.7490000128746033},{"id":"https://openalex.org/keywords/stereoselectivity","display_name":"stereoselectivity","score":0.9200000166893005},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5220000147819519},{"id":"https://openalex.org/keywords/atrioventricular-conduction","display_name":"atrioventricular conduction","score":0.8050000071525574},{"id":"https://openalex.org/keywords/pr-interval-prolongation","display_name":"PR interval prolongation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.6840000152587891},{"id":"https://openalex.org/keywords/systemic-clearance","display_name":"systemic clearance","score":0.7649999856948853},{"id":"https://openalex.org/keywords/oral-versus-intravenous-administration","display_name":"oral versus intravenous administration","score":0.7519999742507935},{"id":"https://openalex.org/keywords/stable-isotope-tracers","display_name":"stable isotope tracers","score":0.6169999837875366},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.9066020250320435},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6970622539520264},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.687357485294342},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6834886074066162},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6000270247459412},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.5683116912841797},{"id":"https://openalex.org/C201253974","wikidata":"https://www.wikidata.org/wiki/Q1330121","display_name":"First pass effect","level":3,"score":0.5636995434761047},{"id":"https://openalex.org/C11824378","wikidata":"https://www.wikidata.org/wiki/Q5014970","display_name":"CYP3A","level":4,"score":0.5466062426567078},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.5077953934669495},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.47976693511009216},{"id":"https://openalex.org/C132154277","wikidata":"https://www.wikidata.org/wiki/Q5381545","display_name":"Enzyme inducer","level":3,"score":0.44404345750808716},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.4407435655593872},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.4373745322227478},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41843026876449585},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3921656608581543},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38906633853912354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3821457326412201},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2862805128097534},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11557522416114807},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.10953068733215332}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004064","descriptor_name":"Digestive System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004790","descriptor_name":"Enzyme Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/hep.510240407","doi":"https://doi.org/10.1002/hep.510240407","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.510240407","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.510240407","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},{"id":"doi:10.1053/jhep.1996.v24.pm0008855178","doi":"https://doi.org/10.1053/jhep.1996.v24.pm0008855178","is_oa":false,"landing_page_url":"https://doi.org/10.1053/jhep.1996.v24.pm0008855178","pdf_url":null,"source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},{"id":"pmid:8855178","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8855178","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology (Baltimore, Md.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/hep.510240407","doi":"https://doi.org/10.1002/hep.510240407","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.510240407","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.510240407","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1964026490.pdf","grobid_xml":"https://content.openalex.org/works/W1964026490.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W161867012","https://openalex.org/W1570746601","https://openalex.org/W1735321013","https://openalex.org/W1892194801","https://openalex.org/W1964017181","https://openalex.org/W1968793073","https://openalex.org/W1979732900","https://openalex.org/W1980412722","https://openalex.org/W1982791610","https://openalex.org/W1983922519","https://openalex.org/W1984579497","https://openalex.org/W1992268549","https://openalex.org/W1996838838","https://openalex.org/W2002044083","https://openalex.org/W2008984280","https://openalex.org/W2011910735","https://openalex.org/W2017581392","https://openalex.org/W2022713088","https://openalex.org/W2024587809","https://openalex.org/W2028568752","https://openalex.org/W2034853089","https://openalex.org/W2043319837","https://openalex.org/W2049576942","https://openalex.org/W2059588998","https://openalex.org/W2061407065","https://openalex.org/W2061591861","https://openalex.org/W2073965718","https://openalex.org/W2078482870","https://openalex.org/W2082453607","https://openalex.org/W2092727769","https://openalex.org/W2094738707","https://openalex.org/W2095385388","https://openalex.org/W2100819311","https://openalex.org/W2103062639","https://openalex.org/W2104093795","https://openalex.org/W2114845550","https://openalex.org/W2114903378","https://openalex.org/W2117722214","https://openalex.org/W2152267898","https://openalex.org/W2156529377","https://openalex.org/W2162606005","https://openalex.org/W2217887151","https://openalex.org/W2309607074","https://openalex.org/W2417980278","https://openalex.org/W2432152611","https://openalex.org/W2461925196","https://openalex.org/W4407031952"],"related_works":["https://openalex.org/W1592099189","https://openalex.org/W2100589837","https://openalex.org/W2023057865","https://openalex.org/W2046692633","https://openalex.org/W1838282487","https://openalex.org/W2064650987","https://openalex.org/W2061357234","https://openalex.org/W2124905894","https://openalex.org/W1977389301","https://openalex.org/W2165537690"],"abstract_inverted_index":{"Cytochrome":[0],"P450":[1],"(CYP)":[2],"enzymes,":[3],"which":[4],"metabolize":[5],"numerous":[6],"drugs,":[7],"are":[8],"expressed":[9],"both":[10,282],"in":[11,14,26,322],"liver":[12],"and":[13,22,52,68,79,96,132,162,181,193,232,284,294,333],"extrahepatic":[15],"tissues.":[16],"CYP3A4":[17,47],"for":[18,145],"example":[19],"is":[20,97,111,326,339],"present":[21],"inducible":[23],"by":[24,170,199,341],"rifampin":[25,220,244],"epithelial":[27],"cells":[28],"of":[29,46,63,71,105,126,130,141,164,186,210,226,253,279,298,319,336],"the":[30,61,72,117,124,165,201,207,211,222,251,292,295,323],"gastrointestinal":[31],"tract.":[32],"It":[33],"has":[34],"been":[35],"shown":[36],"that":[37,316,334],"such":[38],"prehepatic":[39,67,103,131,317],"metabolism":[40,70,318,332,338],"contributes":[41],"substantially":[42],"to":[43,91,100,157,300],"total":[44],"clearance":[45,161,209,225],"substrates":[48],"(e.g.,":[49],"cyclosporine)":[50],"before":[51],"even":[53],"more":[54],"pronounced":[55],"during":[56],"enzyme":[57,64],"induction.":[58,342],"We":[59],"examined":[60],"effect":[62,252],"induction":[65,127],"on":[66,128,175,178,182,188,256],"hepatic":[69,133,331],"model":[73],"compound":[74],"R/S-verapamil":[75],"after":[76,191,243,271,281,305],"simultaneous":[77],"oral":[78,192,224,254,285,306],"intravenous":[80,194,272,283,310],"administration":[81,196,286,307],"using":[82],"a":[83,114,276,301],"stable":[84],"isotope":[85],"technology.":[86],"This":[87],"approach":[88],"allows":[89],"us":[90],"exclude":[92],"intraindividual":[93],"day-to-day":[94],"variability":[95],"therefore":[98],"suitable":[99],"quantitatively":[101],"assess":[102],"extraction":[104],"high-clearance":[106],"drugs.":[107],"Moreover,":[108],"because":[109],"verapamil":[110,143,166,173,187,255,299,320,337],"administered":[112],"as":[113],"race-mate":[115],"with":[116,240,309,330],"S-enantiomer":[118],"being":[119],"preferentially":[120,327],"metabolized,":[121],"we":[122],"investigated":[123],"influence":[125],"stereoselectivity":[129,280,335],"metabolism.":[134],"Eight":[135],"male":[136],"volunteers":[137],"received":[138],"120":[139],"mg":[140,150],"racemic":[142],"bid":[144],"24":[146],"days.":[147],"Rifampin":[148,205,290],"(600":[149],"daily)":[151],"was":[152,259],"given":[153],"from":[154],"day":[155,158,176,179,183],"5":[156],"16.":[159],"Systemic":[160],"bioavailability":[163,235],"enantiomers":[167],"were":[168,197,269],"determined":[169],"coadministering":[171],"deuterated":[172],"intravenously":[174],"4,":[177],"16,":[180],"24.":[184],"Effects":[185],"atrioventricular":[189,257],"conduction":[190,258],"(iv)":[195],"assessed":[198],"measuring":[200],"maximum":[202],"PR-interval":[203],"prolongation":[204],"increased":[206,221],"systemic":[208],"active":[212],"S-verapamil":[213,227],"1.3-fold":[214],"(P":[215,229,237,246,262,287],"<":[216,230,238,247,263,288],".001).":[217,289],"In":[218],"contrast,":[219],"apparent":[223],"32-fold":[228],".001)":[231],"decreased":[233],"its":[234],"25-fold":[236],".001),":[239],"partial":[241],"recovery":[242],"withdrawal":[245],".01).":[248],"With":[249],"rifampin,":[250],"nearly":[260],"abolished":[261],".01),":[264],"whereas":[265],"no":[266],"significant":[267],"changes":[268],"observed":[270],"administration.":[273,311],"Induction":[274],"caused":[275],"considerable":[277],"reduction":[278],"altered":[291],"pharmacokinetics":[293],"pharmacological":[296],"effects":[297],"much":[302],"greater":[303],"extent":[304],"compared":[308,329],"These":[312],"data":[313],"clearly":[314],"indicate":[315],"(presumably":[321],"gut":[324],"wall)":[325],"induced":[328],"affected":[340]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}